Creative Medical Technology (CELZ) Increases Authorized Shares to 100M

What Happened

• Creative Medical Technology Holdings, Inc. (CELZ) filed an 8-K reporting that at a Special Meeting on August 28, 2026 stockholders approved an amendment to the Articles of Incorporation to increase authorized common shares from 25,000,000 to 100,000,000. The company filed a Certificate of Amendment with the Nevada Secretary of State on August 28, 2026.
• At the same meeting, stockholders also approved the proposal to permit the exercise in full of Investor Warrants issued in a June 30, 2026 private placement, which, if exercised, represent an aggregate of 5,580,680 shares of common stock.

Key Details

• Quorum: 3,098,886 shares voted in person or by proxy, representing 65.4% of outstanding common shares as of the record date.
• Share increase vote (Proposal I): For 2,488,537; Against 595,527; Abstain 14,822.
• Investor Warrants vote (Proposal II): For 678,541; Against 344,460; Abstain 17,313; Broker non-votes 1,092,794.
• Certificate of Amendment filed with Nevada on August 28, 2026 (included as Exhibit 3.1 to the Form 8-K).

Why It Matters

• The authorized-share increase creates legal capacity for the company to issue up to 100,000,000 common shares (previously 25,000,000), which the company can use for financings, stock-based compensation, or other purposes.
• Approval of the Investor Warrants allows those warrants (5,580,680 shares in aggregate) to be exercised in full, which would increase the number of outstanding shares if exercised and could dilute existing shareholders.